NRAS and lung carcinoma: Mutations in several genes were found to be good prognostic markers for human cancer; examples include mutated KRAS that was correlated with a poor prognosis of pancreatic [35] and lung cancer [36], and mutated NRAS that was associated with a poor prognosis of metastatic melanoma [37].